![](/img/cover-not-exists.png)
Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
Ready, Neal, Karaseva, Nina A., Orlov, Sergey V., Luft, Alexander V., Popovych, Olexandr, Holmlund, Jon T., Wood, Brian A., Leopold, LanceVolume:
6
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31820a0ea6
Date:
April, 2011
File:
PDF, 195 KB
english, 2011